J9026 Injection, tarlatamab-dlle, 1 milligrams
J-Codes
Also known as: tarlatamab, Talquetamab
Intravenous injection of tarlatamab-dlle, a bispecific T-cell engager monoclonal antibody used for hematologic malignancies, dosed per 1 milligram.
Clinical Context
Used to treat relapsed or refractory B-cell lymphomas by engaging cytotoxic T-cells to attack malignant B-cells. Administered as an intravenous infusion.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.